Sunitinib Malate Market: Key Growth Drivers and Emerging Opportunities

ha aggiunto una foto Altre informazioni

2026-10-01 10:02:10 -

The Sunitinib Malate Market is developing alongside the growing demand for targeted cancer therapies and advances in precision oncology. Sunitinib malate is an oral, multi-targeted tyrosine kinase inhibitor used in the treatment of several cancers, including kidney cancer, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (PNET). According to Polaris Market...

0 Commenti 0 condivisioni 7 Views 0 Anteprima